Cho Nariya, Moon Woo Kyung, Chang Jung Min, Yi Ann, Koo Hye Ryoung, Han Boo-Kyung
Department of Radiology and Clinical Research Institute, Seoul National University Hospital and the Institute of Radiation Medicine, Seoul National University Medical Research Center, Chongno-gu, Seoul, Korea.
Acta Radiol. 2010 Nov;51(9):969-76. doi: 10.3109/02841851.2010.515615.
Supplemental screening ultrasonography (US) in addition to mammography can help detect early breast cancers in women with dense breasts and other risk factors. It is crucial to understand the imaging features of US-detected cancer to identify them in screening population.
To retrospectively evaluate the US features and final assessments of breast cancers detected by supplemental screening US in comparison with cancers seen on screening mammography.
The study included 80 women (mean age 46 years, range 31–65 years) with 80 breast cancers detected by supplemental screening US. Another 80 women (mean age 52 years, range 33–77 years) with 80 breast cancers seen on screening mammography were included for a control group. US features and final assessments were classified according to the Breast Imaging Reporting and Data System (BI-RADS) without knowledge of the method of detection, or mammographic or histologic findings. Results of the two groups were compared.
Breast cancers detected by supplemental screening US were more frequently found to have the following features: an oval shape (21% [17/80] vs 10% [8/80], P = 0.013), a circumscribed margin (13% [10/80] vs 4% [3/80], P = 0.043), an abrupt interface (79% [63/80] vs 53% [42/80], P < 0.001), and no posterior acoustic (70% [56/80] vs 53% [42/80], P = 0.023) or surrounding tissue (79% [63/80] vs 28% [22/80], P < 0.001) changes. For the final assessment, 93% (74/80) of US-detected cancers and 60% (48/80) of cancers seen on mammography were classified as a category 4, while 3% (2/80) of US-detected cancers and 38% (30/80) of cancers seen on mammography were category 5.
Compared with breast cancers seen on screening mammography, breast cancers detected by supplemental screening US tend to have less malignant US features, although most (95%) of them were classified as category 4 or 5.
除乳腺钼靶检查外,补充性筛查超声检查可帮助检测乳腺致密及有其他风险因素的女性中的早期乳腺癌。了解超声检测到的癌症的影像学特征对于在筛查人群中识别这些癌症至关重要。
回顾性评估补充性筛查超声检测到的乳腺癌的超声特征及最终评估结果,并与筛查乳腺钼靶检查中发现的癌症进行比较。
该研究纳入了80名女性(平均年龄46岁,范围31 - 65岁),这些女性通过补充性筛查超声检测出80例乳腺癌。另一组对照组纳入了80名女性(平均年龄52岁,范围33 - 77岁),她们通过筛查乳腺钼靶检查发现了80例乳腺癌。超声特征及最终评估根据乳腺影像报告和数据系统(BI-RADS)进行分类,且不知晓检测方法、钼靶检查结果或组织学结果。比较两组结果。
补充性筛查超声检测出的乳腺癌更常具有以下特征:椭圆形(21% [17/80] 对比10% [8/80],P = 0.013)、边界清晰(13% [10/80] 对比4% [3/80],P = 0.043)、界面突然(79% [63/80] 对比53% [42/80],P < 0.001),且后方回声(70% [56/80] 对比53% [42/80],P = 0.023)或周围组织(79% [63/80] 对比28% [22/80],P < 0.001)无变化。对于最终评估,超声检测到的癌症中有93%(74/80)以及钼靶检查发现的癌症中有60%(48/80)被分类为4类,而超声检测到的癌症中有3%(2/80)以及钼靶检查发现的癌症中有38%(30/80)被分类为5类。
与筛查乳腺钼靶检查中发现的乳腺癌相比,补充性筛查超声检测到的乳腺癌往往具有恶性程度较低的超声特征,尽管其中大多数(95%)被分类为4类或5类。